" Among the key recommendations of the report are the pressing need for both a separate regulatory act for medical technology, as well as for giving manufacturing incentives like tax support and low cost funding to spur investments."
New Delhi, Aug 21 - India's medical technology sector can become a $50 billion industry in the next decade and compete with China in the global market provided industry and the government act together to boost domestic manufacturing, a top official has said .

It is essential that the sector exploits the cost advantage if it wants to compete with China for the global market, Amitabh Kant, secretary, Department of Industrial Policy and Promotion (DIPP), said addressing the 7th Medical Technology Conference organised by the Confederation of Indian Industry (CII) here Wednesday.

Due to its potential, CII is happy to acknowledge the medical technology sector as a sunrise sector, said CII director general, Chandrajit Banerjee.

Medical technology in India is currently just a $6.3 billion industry.

An extensive report on the sector Vision Document - 2025, jointly prepared by CII and Boston Consulting Group, was released on the occasion.

Among the key recommendations of the report are the pressing need for both a separate regulatory act for medical technology, as well as for giving manufacturing incentives like tax support and low cost funding to spur investments.

Classification of medical devices as drugs burdens the process of investment with fiscal policy obstacles and regulatory hurdles. It impacts foreign and local investment, technology transfer, manufacturing, operations, innovation and exports,said Pavan Choudary, chairman, Medical Technology Division of CII.


comments powered by Disqus
Read more on:
 

PERMALINK

http://www.nerve.in/news:2535002397721
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.


STORY OPTIONS
  Email this story to a friend
  XML feed for India


 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.